REMEDi4ALL is an EU-funded research initiative to drive forward the repurposing of medicines in Europe. The platform has the potential to bring down times and costs of drug development by focusing on already approved, discontinued, shelved or investigational therapeutics.

The REMEDi4ALL consortium brings together a unique combination of expertise to address the complexities of drug repurposing. Under the leadership of EATRIS, the European infrastructure for translational medicine, 24 organisations in the fields of clinical and translational research, clinical operations, patient engagement and education, regulatory framework, funding, governance, Health Technology Assessment (HTA) and pricing and reimbursement will closely collaborate to make drug repurposing mainstream.

In REMEDi4ALL, ZonMw has the lead in creating a funders network and ‘think tank’ with the aim to discuss policy issues, share best funding practices, co-ordinate (new) funding streams, promote joint calls and develop innovative co-funding models for drug repurposing. ZonMw will also contribute to improving the market access and policy environment for drug repurposing.

Calling all research funders willing to advance drug repurposing: we would love to hear your experiences & ideas within the International Drug Repurposing Funders Network.

Learn more

On September 1st 2022 REMEDi4ALL launched with the aim of making a major leap forward in drug repurposing.

Read more about de launch

Find out more about the consortium, events, news and opportunities on the official REMEDi4ALL website.

Find out more on the website

Contact the ZonMw-team for specific questions

The REMEDi4ALL team consists of:

  • Heleen van der Meer, senior programmanager
  • Dunja Huijbers, senior programmanager
  • Jet Kraaijvanger, programmasecretaris
  • Claire van Woudenbergh, programmasecretaris

Find more information about the REMEDi4ALL platform on the website.
Questions about the International Drug Repurposing Funders Network can be asked via:

Naar boven
Direct naar: InhoudDirect naar: Onderkant website